Castleman's Disease

Also known as: Castleman Disease / Angiofollicular lymph node hyperplasia (morphologic abnormality) / Angiofollicular lymph node hyperplasia (disorder) / Angiofollicular lymph node hyperplasia (disorder) [Ambiguous] / [D] Castleman's disease (disorder) / Giant lymph node hyperplasia (disorder)

DrugDrug NameDrug Description
DB09036SiltuximabAn interleukin antagonist used to treat multicentric Castleman's disease (MCD) in patients who are HIV and HHV-8 negative.
DrugDrug NamePhaseStatusCount
DB00220Nelfinavir0Terminated1
DB00112Bevacizumab1Recruiting1
DB00002Cetuximab1Recruiting1
DB00825Levomenthol1Recruiting1
DB15408Silmitasertib1Unknown Status1
DB00877Sirolimus1Recruiting1
DB06287Temsirolimus1Recruiting1
DB06273Tocilizumab1Completed1
DB00313Valproic acid1Recruiting1
DB00877Sirolimus2Recruiting1
DB06273Tocilizumab2Completed1
DB01610Valganciclovir2Completed1
DB00495Zidovudine2Completed1